NCT02423356View on ClinicalTrials.gov

Strain Echocardiography to Predict Cardiotoxicity in Patients Receiving Chemotherapy Containing Doxorubicin

CompletedOBSERVATIONAL
Enrollment

12

Participants

Timeline

Start Date

April 23, 2015

Primary Completion Date

February 1, 2018

Study Completion Date

February 1, 2018

Conditions
Breast NeoplasmsLymphomaSarcoma
Interventions
PROCEDURE

Echocardiogram

An echocardiogram uses sound waves to produce images of the heart. This commonly used test allows doctors to see how your the heart is beating and pumping blood. Doctors can use the images from an echocardiogram to identify various abnormalities in the heart muscle and valves.

Trial Locations (2)

46202

Indiana University Health Hospital, Indianapolis

Indiana University Melvin and Bren Simon Cancer Center, Indianapolis

All Listed Sponsors
lead

Daniel Rushing

OTHER

NCT02423356 - Strain Echocardiography to Predict Cardiotoxicity in Patients Receiving Chemotherapy Containing Doxorubicin | Biotech Hunter | Biotech Hunter